Colloidal NADH

- Jeff LaBar

People with Parkinson's disease stop trembling, people with Alzheimer's disease stop forgetting, and everybody else gets a quick pick-me-up from fatigue - all with a new natural substance that excites me more than any other discovery in the past decade.
Robert C. Atkins, MD, "Dr. Atkins' Health Revelations", Vol. III, Number 6, June 1995

Dr. Atkins continues, You probably haven't heard of NADH, also called Coenzyme 1, but you will. This enzyme is the stored form of energy in every cell in our bodies, and it's now available - without prescription - as a supplement. NADH is more effective against Parkinson's disease than the standard treatment, L-dopa. And it's the only promising therapy I see for the heretofore incurable Alzheimer's. As use and research grow, the first governmentally sanctioned clinical test in the US is expected to begin later this year (1995). I'm convinced it will become par for the course in alleviating depression, fatigue and even minor mental sluggishness.

Parkinson's Potion?

I was already well-informed about NADH when Georg Birkmayer, MD, the world's chief NADH researcher came to the Foundation for the Advancement of Innovative Medicine symposium in March (1995). But even I was taken aback when Birkmayer, director of the Birkmayer Institute for Parkinson's Therapy in Vienna, played a videotape of three of his patients before and after treatment with NADH.

If you've ever watch a Parkinson's patient shuffle hesitantly across a room with arms trembling and head wobbling, you'll know what we saw on the tape before NADH was administered. Several hours after receiving NADH, the same people were shown getting up with relative ease and walking briskly. The only difference was NADH.

Since 1988, Birkmayer and his father, Walter Birkmayer, MD, have used NADH to treat more than 885 people with
Parkinson's disease. Eighty percent of those people showed moderate to excellent improvements in their disability (Acta Neurologica Scandinavia, 1993; 87 [Suppl 146]:32-35). The younger Birkmayer believes that most of the people who didn't improve had advanced arteriosclerosis that prevented the coenzyme from reaching the brain.

Far more important than the initial improvements is that those people have not deteriorated at all in the years since NADH treatments began. Most of them have been able to discontinue or decrease their use of L-dopa.

Alzheimer's Advance Until Birkmayer began giving NADH to a smaller group of people with Alzheimer's disease, no glimmer of hope existed in the treatment of this dreaded destroyer of memory. Since Alzheimer's and Parkinson's share many biochemical similarities, including an Alzheimer's-like dementia in the later stages of Parkinson's, Birkmayer decided to test NADH against Alzheimer's.

All of the 17 people with Alzheimer's who received supplements of the coenzyme showed significant improvements on
standard memory test, according to unpublished test results. And for the past two years, further brain deterioration has been stopped in its tracks.

Free from Fatigue

And now for the rest of us. I can't state it any more simply than this: Supplements of NADH increase your energy levels.
Evidence so far suggests that NADH will become a safe, commonly used supplement to relieve depression, memory lapses, and concentration difficulties. People with family histories of Alzheimer's might want to consider taking NADH to prevent mental deterioration.

The case history below offers a good example of NADH's benefits and illustrates a guiding principle in its use: The dose is critical to the result. Based on what's happened with many of my patients who turned to NADH in search of their misplaced energy, people don't start to feel better until they take the dosage that's right for their own bodies.

If you take too little, you won't notice anything. If you take too much, you'll become hyperactive and won't be able to fall
asleep easily. If someone doesn't derive an energy boost from an initial (serving) every other day, I advise him or her to
gradually increase the dose until he or she becomes sleepless or restless, then decrease to a slightly lower amount.

If the lower dose doesn't enhance energy - and there have been few of my patients for whom it has not - then you can
conclude that NADH doesn't work for you. But the vast majority of my patients have enjoyed a significant boost in vigor.

Secret to the Success

While NADH (short for nicotinamide adenine dinucleotide) is one of the critical chemical stages in the process by which our bodies create energy, this action probably is not the main reason for its remarkable impact on Parkinson's and
Alzheimer's. In the brain, it increases the production of dopamine, the neurochemical responsible for coordination and
control of movements. People with Parkinson's disease have damage to a portion of the brain's basal ganglia ,which causes a shortage of dopamine.

So far, doctors have treated Parkinson's with the drug L-dopa, which the body converts to dopamine. However, direct
L-dopa therapy usually becomes less effective as the years pass, and is often ends up damaging the brain. So the prognosis for people with Parkinson's has been fairly grim.

NADH, though, increases the body's own natural production of dopamine, according to Birkmayer and an independent
research team at the University of Paris.

In Alzheimer's, the dopamine increase and a boost in another brain chemical, noradrenaline, combine with NADH's
productions of energy to somehow protect the neural pathways in the brain, believes Dr. Birkmayer. This stops further brain damage.

*The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent disease. If you have or suspect a medical condition, consult your healthcare professional prior to use.

Wizards Gate is dedicated to bringing this valuable supplement to you at the lowest possible prices, and FREE Priority Mail Shipping when ordering two or more of any size ENADA®

To order ENADA® NADH The Energizing Coenzyme, click below

  WB00678_.gif (615 bytes)  ORDER NOW  WB00677_.gif (630 bytes)